Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Csernok

Showing results (31-40 of 107) with videos related to

Pageof 11
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1997
Interaction of transforming growth factor beta (TGF beta) with proteinase 3J Kekow, E Csernok, C Szymkowiak, et al.
Clinical and Experimental Rheumatology|April 13, 2007
A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3B Hellmich, E Csernok, G Fredenhagen, et al.
Clinical and Experimental Immunology|October 9, 1998
Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cellsF Moosig, E Csernok, G Wang, et al.
Clinical and Experimental Immunology|December 21, 2000
Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha)F Moosig, E Csernok, G Kumanovics, et al.
Journal of Immunological Methods|January 20, 1998
Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA)G Wang, E Csernok, K de Groot, et al.
Immunitat Und Infektion|April 1, 1993
[Wegener's granulomatosis and ANCA-associated vasculitis: pathogenic role of autoantigens, autoantibodies, and cytokines]J Kekow, E Csernok, C H Szymkowiak, et al.
The American Journal of Pathology|November 1, 1990
Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosisE Csernok, J Lüdemann, W L Gross, et al.
The Journal of Rheumatology|June 1, 1994
Antineutrophil cytoplasmic antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patientsS Hauschild, E Csernok, W H Schmitt, et al.
Arthritis and Rheumatism|March 20, 1998
Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et alF Moosig, E Reinhold-Keller, E Csernok, et al.
The European Respiratory Journal|September 18, 1999
Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activityA Schnabel, M Reuter, E Csernok, et al.
Pageof 11

Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Advances in Experimental Medicine and Biology|January 1, 1997
Interaction of transforming growth factor beta (TGF beta) with proteinase 3J Kekow, E Csernok, C Szymkowiak, et al.
Clinical and Experimental Rheumatology|April 13, 2007
A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3B Hellmich, E Csernok, G Fredenhagen, et al.
Clinical and Experimental Immunology|October 9, 1998
Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cellsF Moosig, E Csernok, G Wang, et al.
Clinical and Experimental Immunology|December 21, 2000
Opsonization of apoptotic neutrophils by anti-neutrophil cytoplasmic antibodies (ANCA) leads to enhanced uptake by macrophages and increased release of tumour necrosis factor-alpha (TNF-alpha)F Moosig, E Csernok, G Kumanovics, et al.
Journal of Immunological Methods|January 20, 1998
Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA)G Wang, E Csernok, K de Groot, et al.
Immunitat Und Infektion|April 1, 1993
[Wegener's granulomatosis and ANCA-associated vasculitis: pathogenic role of autoantigens, autoantibodies, and cytokines]J Kekow, E Csernok, C H Szymkowiak, et al.
The American Journal of Pathology|November 1, 1990
Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosisE Csernok, J Lüdemann, W L Gross, et al.
The Journal of Rheumatology|June 1, 1994
Antineutrophil cytoplasmic antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patientsS Hauschild, E Csernok, W H Schmitt, et al.
Arthritis and Rheumatism|March 20, 1998
Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et alF Moosig, E Reinhold-Keller, E Csernok, et al.
The European Respiratory Journal|September 18, 1999
Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activityA Schnabel, M Reuter, E Csernok, et al.
Pageof 11